Abstract-We have witnessed an accelerated growth of photonics technologies in recent years to enable not only monitoring the activity of specific neurons, while animals are performing certain types of behavior, but also testing whether specific cells, circuits, and regions are sufficient or necessary for initiating, maintaining, or altering this or that behavior. Compared to other sensory systems, however, such as the visual or olfactory system, photonics applications in pain research are only beginning to emerge. One reason pain studies have lagged behind is that many of the techniques originally developed cannot be directly implemented to study key relay sites within pain pathways, such as the skin, dorsal root ganglia, spinal cord, and brainstem. This is due, in part, to difficulties in accessing these structures with light. Here we review a number of recent advances in design and delivery of light-sensitive molecular probes (sensors and actuators) into pain relay circuits to help decipher their structural and functional organization. We then discuss several challenges that have hampered hardware access to specific structures including light scattering, tissue movement and geometries. We review a number of strategies to circumvent these challenges, by delivering light into, and collecting it from the different key sites to unravel how nociceptive signals are encoded at each level of the neuraxis. We conclude with an outlook on novel imaging modalities for label-free chemical detection and opportunities for multimodal interrogation in vivo. While many challenges remain, these advances offer unprecedented opportunities to bridge cellular approaches with context-relevant behavioral testing, an essential step toward improving translation of basic research findings into clinical applications.
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Neuroscience 338 (2016) depends on the development of innovative approaches to study the organization of brain microcircuits and the dynamic mechanisms that govern their function across a broad range of scales: from synapses -and even nanoscale substructures within synapses-to entire microcircuits in the intact brain during behavior. Lightbased tools represent the disruptive, enabling technology in this endeavor. Light has just the right energy (i) to non-destructively probe or control biological molecules (proteins, ion channels, receptors, lipids), enabling non-invasive studies and interventions, and (ii) to image ultra-rapidly at spatial resolutions down to the nanoscale. Thus, by exploiting light with proper tools, one can gain access, at one end, to molecular signaling events at single synapses, and at the other end, to whole animal physiology and behavior, providing the opportunity to bridge the different levels of complexity of brain functions.
A number of revolutions that occurred over the last decades now converge to make the use of light the tool of choice to enable cracking the neural code and the pain code. First, the introduction of fluorescence microscopy transformed life sciences by making molecular imaging possible in live cells and tissues at unmatched spatial resolution and speed. But it is the many flavors of nonlinear optical interactions, enabled by the advent of robust ultrafast pulsed lasers, that turned this transformation into a revolution. Their highly confined interaction volumes limit the photodamage, increase the spatial resolution, and offer optimal light collection strategies for imaging in deep tissue (Denk et al., 1990; Stosiek et al., 2003; Zipfel et al., 2003; Helmchen and Denk, 2005; Lutcke and Helmchen, 2011) . Then by exploiting clever beam shaping strategies, or the properties of fluorophores, it has been possible to push spatial resolution beyond the diffraction limit (Hell and Wichmann, 1994; Betzig et al., 2006; Rust et al., 2006) . Beyond fluorescence, nonlinear interactions provide endogenous contrast mechanisms sensitive to molecular symmetry and orientation (e.g., high harmonic generation imaging) and biochemical species (e.g., Raman spectroscopy).
The advent of photoactivatable proteins to generate novel sensors and actuators is another revolution that has opened an immense array of possibilities to dramatically enhance the throughput of microcircuit dissection, enabling the monitoring and control of the activity of hundreds to thousands of cells simultaneously, with genetic specificity (Hamel et al., 2015) . The possibilities do not end there, as the growing array of genetically-encoded tools expands, almost on a weekly basis, to enable monitoring a multitude of cellular events (not just ions, but also enzymatic reactions and molecular arrangements) and to enable control of a similar multitude of events (triggering/stopping enzymatic reactions, releasing and ablating molecular components). And these occur in an ever growing palette of spectral ranges, opening avenues for multiple simultaneous interventions across cells populations, and even within different cell compartments (Zhao et al., 2011b; Zou et al., 2014; Shen et al., 2015) . The paradigm shift here is that, for the first time, specificity in sensing or stimulating in the CNS is not only determined by spatial factors, (i.e., by the precision of the light delivery or collection system) thus allowing precise probing yet within highly entangled neural circuits. It is this asset that makes optogenetics particularly enabling: to conduct precise cellular and molecular signaling manipulations in the intact brain of a behaving animal, hence in relevant context.
Parallel developments in optical fibers and microoptical components, to carry light without aberrations, have enhanced the realm of possibilities for miniaturization and local sensing deep in tissue in freely behaving animals (Dufour and De Koninck, 2015) . Nevertheless, challenges remain to harness the full potential of optical approaches and optical probes due to diffraction, absorption and scattering which restrict resolution and depth of observation or intervention.
The purpose of this review is to provide an overview of the different optical approaches being developed that can be exploited to probe neural mechanisms within the different components of pain pathways, from skin to cortex. These approaches can be divided into two general categories: visualizing (static structures, dynamic molecular interactions and neuronal activity) and manipulating (modifying or breaking molecular configuration). This involves tools at both ends: at the receiving end, in the tissue, the wetware, i.e., molecular components incorporated into cells to produce the signal, and at the other end, the hardware, i.e., laserbased microscopy and fiber-optics technologies to send light to the appropriate place and collect it to interpret the signal. Emphasis will be placed on promises (opportunities) and limitations (challenges) each approach presents. We will first briefly summarize the chemical and genetically-encoded probes to monitor (fluorescent sensors) and control (actuators) neuronal activity. We will focus on strategies and challenges to deliver these probes within the proper compartments of pain pathways (e.g., sensory afferents, spinal cord). We will then discuss the different microscopy and fiber optics-based technologies that can be used to make maximal use of these probes to decode how signals are encoded at each level of the neuraxis (at the molecular, cellular, circuit and behavioral levels). We will finally describe how light-based technologies can be exploited to probe without extrinsic labels, which is critical for clinical applications.
SENSORS
A wide array of chemical probes has been developed over the years to enable optical monitoring of neuronal activity and cell signaling events with high spatial and temporal resolution. These have been extensively discussed in recent reviews (Knopfel et al., 2006; Grienberger and Konnerth, 2012; Kilgore et al., 2014; Loew, 2015) . Here we focus specifically on the genetically-encoded sensors (Ca 2+ , voltage, glutamate and intracellular signaling pathways) because they offer the advantage of being targeted to specific populations of cells, that represent components of nociceptive pathways.
Genetically-encoded activity sensors
Genetically encoded indicators of neural activity (GINAs) have been developed to transduce Ca 2+ or voltage fluctuations into changes in fluorescence (Looger and Griesbeck, 2012) . GINAs are based on chimeric fluorescent proteins (FPs), and as they are encoded by DNA, they can be targeted to genetically-defined cell populations. Combined with fluorescence microscopy, GINAs offer the ability to monitor activity from a wide array of individual cells within a circuit (e.g., sensory ganglion, spinal cord, thalamus, cortex) (Greenberg et al., 2008; Kerr and Denk, 2008; Kerr and Nimmerjahn, 2012) , but also within small cellular components that have remained particularly difficult to access with electrophysiological techniques (e.g., sensory afferent terminals in peripheral tissue or axonal boutons), an application that remains to be developed and that will be particularly enabling to understand signal transduction in sensory receptors and presynaptic modulation. Genetically-encoded Ca 2+ indicators (GECIs) typically consist of a calcium-binding domain (e.g., calmodulin or troponin C), fused to one or two FP (Tian et al., 2012) . In GECIs with single-FP, such as GCaMPs and GECOs, the fluorescence intensity of the circularly permuted or split FP is controlled by Ca 2+ -dependent changes in the chromophore environment (Akerboom et al., 2009 ). In GECIs with two-FP, like D3cpV, binding to Ca 2+ allosterically changes the relative emission spectra of the donor-acceptor pair through change in Fo¨rster resonance energy transfer (FRET) (Tian et al., 2012) . Recent developments in protein engineering have dramatically improved the performance of GECIs, to the point of making them the sensors of choice to monitor Ca 2+ in live cells. Improvements include widening the palette of excitation and emission spectra, Ca 2+ affinity, kinetics, dynamic range, and subcellular targeting of different GECIs (Broussard et al., 2014; Rose et al., 2014; Shen et al., 2015) . While there is still room for further improvements on some of the parameters, sensor linearity, toxicity and resistance to lysosomal targeting remain key challenges (Rose et al., 2014; Inoue et al., 2015; Shen et al., 2015) . The choice of optimal sensor for an application often entails a compromise between different characteristics (e.g., sensitivity vs. kinetics) as for any chemical-based Ca 2+ sensor (Grienberger and Konnerth, 2012) . The fact that these Ca 2+ sensors act as buffers incorporates measurement biases and causes them to interfere with function, which needs to be taken into consideration when interpreting the data. Cellular trafficking issues remain a challenge particularly with the redshifted variants . The circularly permuted (GCaMPs and GECOs) have been more widely used, yet FRET-based sensors offer certain advantages that can make them more suitable for certain applications. For example, they can serve as ratiometric indicators, which can be instrumental to measure steady state Ca 2+ levels and to avoid various background signals; they may also offer improved dynamic range and more linear response properties (Thestrup et al., 2014) . The field of genetically-encoded voltage indicators (GEVIs) has grown very rapidly in recent years, again bringing the GEVI to a range where they are usable for many application. Several strategies have been used to engineer them. The two predominant solutions have been FRET-based sensors or more recently sensors based on microbial rhodopsins (Akemann et al., 2010; Broussard et al., 2014; StPierre et al., 2015; Storace et al., 2015) . While GEVIs potentially offer advantages over GECIs that they provide a direct readout of voltage and thus are more proximal indicators of electrical activity, their use still suffers from limited sensitivity, insufficient dynamic range, and slow kinetic properties (Storace et al., 2015) . It is important to note this is a consequence of the limited number of photons produced during the short action potential compared to the longer Ca 2+ waves, which leads to a sizable noise in the signal (shot noise). For this reason, GECIs have remained the main tool used to report neuronal activity. Yet, it should be noted that while GECIs are very often used to monitor firing activity of neurons, in many instances, it is the Ca 2+ fluctuations themselves that are the signal of interest (e.g., presynaptic release, Ca 2+ oscillations in neurons or glia). This is true for other ions as well and the development of other ion sensors (e.g., H + , Na
) is an essential step to be able to completely decipher information coding by neurons and glia (Kuner and Augustine, 2000; Grimley et al., 2013; Lindenburg et al., 2013; Doyon et al., 2016; Hessels et al., 2016; Lee et al., 2016) . Where GEVIs will be particularly instrumental is to measure electrical responses in cellular compartments that are not easily accessible to electrophysiological techniques, such as sensory receptors in peripheral tissue or axon terminals (e.g., primary afferent terminals in the spinal dorsal horn). GEVIs may also be transformative in allowing to measure membrane potential fluctuations in spatially ramified compartments of cells (e.g., voltage propagation along dendrites or at different synapses within a dendrite or across dendrites). However, the current signal-to-noise (SNR) they yield remains insufficient to allow robust measurement of individual events (i.e., without signal averaging and hence lower temporal resolution).
Genetically-encoded neurotransmitter sensors
Beyond monitoring neural activity, direct monitoring of chemical signaling between cells is key to understand signal processing. The most used neurotransmitter sensors to date have been glutamate sensors, including FLIPE (Okumoto et al., 2005) , GluSnFR (Tsien, 2005) , super-GluSnFR (Hires et al., 2008) , and iGluSnFR (Marvin et al., 2013) . They are based on the glutamatebinding domain and a reporter element (a single FP or two FPs). To date, iGluSnFR offers the highest sensitivity, photostability, and a superior SNR (Marvin et al., 2013) . On the other hand, FLIPE, GluSnFR and superGluSnFR are FRET-sensors, which may be useful to measure steady state levels. The sensitivity of the probes allow for measurement of release events at singlesynapse, and even clearance (Liang et al., 2015; Parsons et al., 2016) but can also be used to monitor propagation of activity at the network scale, using transmitter release as a proxy . Another strategy to generate neurotransmitter reporters has been to use stable expression of a specific G protein-coupled receptor (e.g., M1 for ACh, D2 for Dopamine, a 1A adrenergic for norepinephrine) in HEK293 cells, which express Gq/11 G proteins and a Ca 2+ sensor. The cells can be embedded into the tissue and ambient transmitters can activate the receptor to trigger a Ca 2+ signal in the reporter cell (Nguyen et al., 2010; Muller et al., 2014) . Other transmitter sensors are emerging (ATP, GABA (Liang et al., 2015) ), but development of neuropeptide reporters will be particularly instrumental to decode complex synaptic signaling at all levels in pain pathways.
Sensors for intracellular signaling pathways
Perhaps even more transformative is the ability to monitor intracellular signaling events in intact tissue. GFP-based fluorescent sensors have been developed for cAMP, receptor tyrosine kinases, and other molecules (Miyawaki, 2003; Souslova and Chudakov, 2007) . Different strategies have been used; for instance, both GFP tagged PKA (Zaccolo et al., 2000) and EPAC-based FRET probes (Ponsioen et al., 2004) have been developed for cAMP detection. For receptor tyrosine kinases, Raichu is a hybrid protein consisting of H-Ras and the Ras binding domain of Raf, and it could be used to detect the activation of Ras, as a readout of the activation of receptor tyrosine kinases (Mochizuki et al., 2001 ). PercevalHR was developed as a genetically-encoded biosensor of ATP-to-ADP ratio (Tantama and Yellen, 2014) , based on a protein sensor, GlnK, which binds both MgATP and ADP (Berg et al., 2009 ), coupled to a reporter domain, based on a circularly permuted version of Venus. It senses the ATP/ADP ratio because the fluorescence spectrum resulting from MgATP binding is different from that of ADP binding. Also, intracellular level of PIP3 can be monitored by PIP-SHOW, which will translocate from the cytosol to the plasma membrane when the concentration of PIP3 increases. Thus, the membrane/cytosol ratio of PIP-SHOW can serve as a readout of the PIP3 concentration (Mishina et al., 2012) . Several of these sensors described above have pH sensitivity (YFP and the circularly-permuted GFP used in many of these sensors operate on the basis of H + quenching) that needs to be taken into account, either by running control experiments with pH-only sensors (we used for example a variant of clomeleon that is Cl À insensitive but retains pH sensitivity; (St-Pierre et al., 2015) ) or by combining with pH sensors with spectral properties (e.g., pHRed) that are compatible with those of the sensor being used (Tantama and Yellen, 2014) .
ACTUATORS
Besides monitoring, manipulating activity of specific neurons, precisely, within very short temporal windows, is necessary to uncover the causal relationships between certain elements of neural circuits and behaviors. Optogenetics has been revolutionizing in this context because of the ability to control defined subcomponents of neural circuits with specificity and temporal precision comparable to that of the normal electrical activity of neurons, and independent of spatial precision (i.e., the light stimulus does not have to be confined to a specific cell or cell compartment) Tye and Deisseroth, 2012; Grosenick et al., 2015; Rajasethupathy et al., 2016) . While many tools have been developed, in recent years, the opsin-based tools have dominated the scene, in part because they are single-component actuators, greatly enhancing robustness and ease of use (Deisseroth, 2015; Kandori, 2015; McIsaac et al., 2015) . The topics of opsins in neuroscience has been the subject of numerous reviews (e.g., Zhang et al., 2010 Zhang et al., , 2011 Adamantidis et al., 2014; Gautier et al., 2014; Zhou et al., 2015) . Similar to sensors, development challenges include channel kinetics, conductance, ion selectivity, spectral bandwidth and trafficking (Gunaydin et al., 2010; Lin, 2011; Mattis et al., 2012; Tye and Deisseroth, 2012; Klapoetke et al., 2014) . These properties have been important limitations for their use in pain pathways. For example, the small single-channel conductance of channelrhodopsin-2 (ChR2) means that high level of the protein has to be expressed to produce excitation. This has been a limiting factor for the control of certain cell types or within certain cellular compartments. For example, initial attempts at expressing ChR2 in sensory afferents failed to yield an effective tool for excitation across the skin (Wang and Zylka, 2009 ) and only strategies boosting expression levels such that sufficient opsins were expressed at sensory receptor endings yielded an effective remote activation of afferents (Daou et al., 2013) . As will be discussed below, remote control across highly scattering tissue, such as skin and brain, which minimizes excitation efficiency, has also been dramatically improved by using red-shifted opsins (Lin, 2011; Tye and Deisseroth, 2012; Lin et al., 2013; Klapoetke et al., 2014; Rajasethupathy et al., 2015) . The expanding palette of spectrally-shifted opsins opens avenues for selective activation (and inactivation) simultaneously, using different wavelengths of light, but the approach remains limited by overlap in excitation bandwidths; proper calibration and care are required to effectively separate them (Zhang et al., 2011; Chuong et al., 2014; Klapoetke et al., 2014; Rajasethupathy et al., 2015) . Challenges with inhibitory opsins include the fact that most of them have been based on ion pumps (Cl À for Halorhodopsin, NpHR; H + for Archaerhodopsin, Arch and ArchT) (Han and Boyden, 2007; Zhang et al., 2007; Chow et al., 2010; Han et al., 2011) , with potential side effects, such as collapse in Cl À gradients (Gradinaru et al., 2007; Raimondo et al., 2012) and pH changes (Mahn et al., 2016) . Rebound excitation, due to [Cl À ] i accumulation following the end of NpHR activation, for example, can confound interpretation of results (Gradinaru et al., 2007; Raimondo et al., 2012) . The recent advent of Cl À permeable opsins may prove instrumental (Berndt et al., 2014; Govorunova et al., 2015; Wietek et al., 2015) , with the caveat that one still has to consider differences in Cl À homeostasis among cells types and that the complex interplay between Cl À and other ionic and cellular processes can yield unintuitive results (Doyon et al., 2011 (Doyon et al., , 2016 Mahn et al., 2016) . In fact, even so-called shunting inhibition is affected by labile Cl À homeostasis (Doyon et al., 2016) .
A critical revolution in the field of optogenetics, and in particular pain optogenetics, is the advent of lightactivated G protein-coupled receptors (OptoXR) (Airan et al., 2009; Bruchas and Roth, 2016) or soluble (bacterial cyclase) receptors (Stierl et al., 2011) . For example, a light-activated l-opioid receptor (Opto-MOR) was developed by fusing the intracellular component of Opto-MOR with the photoisomerizing retinal binding site of the rat rhodopsin RO4 (Airan et al., 2009; Siuda et al., 2015) . These open new avenues, first to study the role of these signaling mechanisms in specific functions, but also because they couple to effector mechanisms through intracellular signaling pathways with the potential for amplification, yielding more efficient excitation or inhibition than conventional opsins. OptoXR can be used to drive the function of G q , G s , or G i , respectively, for example, offering a wide array of options (Airan et al., 2009; Bruchas and Roth, 2016 ). Yet, the possibilities opened by optogenetics do not stop there, in particular with the advent of photoactivatable enzymes. For example, photoactivatable Cre recombinases (Schindler et al., 2015; Taslimi et al., 2016) open avenues for spatially and temporally selective activation of genes. Similarly, photocleavable proteins open a wide array of opportunities for enzyme uncaging (Rathert et al., 2007; Umeda et al., 2011; Zhou et al., 2015) . A new class of biosensors was also developed based on the reversible exchange of the heterodimeric partners of green and red proteins, whose fluorescence intensity is dimerization dependent (Ding et al., 2015) . This strategy was used to visualize caspase activity upon binding and differential targeting of the substrate fragments after cleavage (Ding et al., 2015) .
TARGETING
A key challenge, whether using chemical or geneticallyencoded reporter or actuators, is their introduction into cells, and especially into the proper target cells. Here we focus on approaches and challenges that are particularly relevant to pain pathways, especially sensory neurons and spinal pathways.
Loading of chemical dyes
While genetically-encoded markers offer many advantages over conventional chemical labeling approaches, the latter still have their niche and in many instances remain the technique of choice (for reviews, see Ribeiro-da-Silva and De Koninck, 2002; Marks and Nolan, 2006; Lazarov, 2013) . For morphometric analyses, intracellular injection of dyes (Fig. 1B) remains the reference to ensure complete labeling of the finest dendritic profiles, for example, and non-fluorescent labels can provide more reliable quantification than fluorescent ones for analysis of small cellular compartments where rapid photobleaching can become a liability (Wong et al., 2000; Cordero-Erausquin et al., 2009; Allard et al., 2012) . Photoconversion of fluorescent dyes or their detection by antibodies is an alternative offering the advantage that the cells can rapidly be identified after intracellular labeling, followed by detailed morphometric analysis after conversion or immunodetection to yield electron-dense material, compatible with ultrastructural analysis (Buhl and Lubke, 1989; Bories et al., 2013) . Intracellular labeling remains the technique of choice for combined morphometric and functional analysis (Prescott and De Koninck, 2002; Ribeiro-da-Silva and De Koninck, 2002; Labrakakis et al., 2009 ), but juxtacellular labeling has been particularly instrumental for in vivo studies (Pinault, 2011) . For targeting specific cells types, retrograde labeling with chemical dyes, or chemically-tagged proteins (e.g., latex microspheres, DiI, biotinylated dextran amines, fluorescently-tagged beta subunit of cholera toxin), remains a technique of choice (Buhl and Lubke, 1989; Yu et al., 1999 Yu et al., , 2005 Chery et al., 2000; Kobbert et al., 2000; Vercelli et al., 2000) Fig . 1B ). Drawbacks of retrograde labeling techniques include missed labeling when terminals are very sparsely distributed in the target nucleus (false negative) or labeling of en passant axons (false positives). Single, juxtacellular cell labeling followed by anterograde tracing, while very laborious, is one approach that has served to unequivocally determine projection patterns (Wu et al., 2000; Parent and Parent, 2006) .
For functional imaging, chemical Ca 2+ dyes have long been the tool of choice. Beyond intracellular single-cell labeling during electrophysiological recording, the most popular loading technique has been using acetoxymethyl ester (AM) forms of the dyes, which can be loaded into neurons though bolus tissue injections (Coull et al., 2003; Cordero-Erausquin et al., 2005) . The approach works in vivo as well (e.g., using local pressure ejection after laminectomy) (Johannssen and Helmchen, 2010; Laffray et al., 2011; Ran et al., 2016) . The depth and range of labeled cells are mainly determined by the depth of the tip of the glass pipette, the amount and concentration of dye used, and the speed of injection, which need to be optimized empirically. Differential loading of neurons vs. glia varies with dye, tissue and preparation (e.g., culture, slices vs in vivo; Oregon Green BAPTA-AM appears to load preferentially in neurons in vivo, but this is not necessarily the case in other preparations). Combining bolus loading of Ca 2+ dyes with neuronal-or glial-specific markers is often used to separate the two populations (Romanelli et al., 2013) . While chemical voltage dyes have not robustly translated into usable tools for single-cell studies they have proven instrumental for mesoscopic functional studies in the cortex (Lim et al., 2015) . The approach has been used to measure activity within cortical surfaces located just below the cranium; in contrast, cortical structures typically associated with pain (ACC and Insula) are much deeper structures. Even more problematic is the brainstem and spinal cord, which is covered with a heavy layer of myelinated fibers. It is therefore unlikely that such an approach will be usable for activity mapping at the mesoscale within pain pathways.
Transducing genetically-encoded sensors and actuators -transgenic strategies
For in vivo studies, GINAs or opsins are typically targeted using transgenic or viral-vector-mediated strategies. Conventional knock-in or transgenic approaches (based on BAC or simpler cDNA transgenes) have been used (Arenkiel et al., 2007; Wang and Zylka, 2009; Zhao et al., 2011a) . Overexpression of the transgene may be problematic in some cases (Kramer et al., 2011) and specificity of the transgene expression needs to be confirmed. A more versatile approach is the use of well characterized transgenic mice expressing Cre recombinase under a specific promoter (Agarwal et al., 2004; Stirling et al., 2005 ; credrivermice.org), coupled with mouse lines encoding the protein of interest whose expression is Cre-dependent. Limitations in using Credependent strategies include ''leakiness", but also developmental shifts in expression. The expression of many genes are known to fluctuate dramatically during the early development or switch from one population of neurons to another (Cavanaugh et al., 2011; Peirs et al., 2015) . Transient expression of Cre can be sufficient to cause expression of the target transgene throughout the life, yielding off-target expression of GINAs or opsins in undesired cells. Strategies to circumvent this include the use of inducible Cre recombinase systems (tamoxifen = CRE-ER or tetracyclin = Tet-ON-Off based). These approaches still have drawbacks including smaller expression range of the Cre-induced exogenous protein vs. that of Cre itself, which is dependent on the dose of the chemical inducer and, in the case of the Tet approach, a third genetically encoded component (tetracyclin activator protein rtTA) which adds to the complexity of the system (Jullien et al., 2008; Wang, 2009 ). An emerging powerful alternative is the use of intersectional genetics (Prescott et al., 2014) . In the latter case, a combination of FLPo and Cre recombinase expression driven by different promoters is used, combined with a target gene whose expression depends on both FLPo and Cre. Only cells expressing both types of recombinase will express the gene, confining targeting more precisely. Yet a major limitation of the use of recombinase-dependent transgenic mice is the time it takes to generate them. Given the rate at which optogenetic tools evolve, often several new iterations of the constructs have evolved by the time the mouse is generated. Here a case for retrograde and trans-synaptic labeling is illustrated, either using a FP-chimera (e.g., GFP-TTC) or a transsynaptically transported viral vector (e.g., pseudorabies). (D). Retrograde transduction can be used an intersectional approach, combining retrograde transport of a Cre expressing AD viral vector, injected in the thalamus, followed by local spinal injection of AAV vector encoding a Credependent FP.
Viral vector-mediated transduction
Largely due to the short experimental time associated with their production, viral vectors have become a very attractive alternative to the generation of genetically modified mouse lines (Lentz et al., 2012; Kantor et al., 2014; Murlidharan et al., 2014) . They can be injected postnatally on their own to express some of the tools mentioned above (GINAs or others) or to deliver recombinases such as Cre, which may help circumvent some of the leakiness problems often encountered when Cre is expressed during embryogenesis and early postnatal stage. Viral vectors can be designed to use strong promoters and yield significant amplification of expression, which is often critical with the expression of opsins (see above and Daou et al., 2013) . (Towne et al., 2009; Kao et al., 2010; Vulchanova et al., 2010) (however see Li et al., 2016) . As with brain regions, one has to revert to intra-spinal injection of AAVs (or lentiviruses). Fortunately, this typically results in selective transduction of dorsal horn neurons with no expression in sensory afferents (DRG), which is instrumental for selective targeting of CNS vs. PNS (Tappe et al., 2006; Lu et al., 2015) . A drawback for intra-spinal injection is the invasive surgery of laminectomy required for the injection, although, in mice, injection can be performed between vertebrae without laminectomy (Tappe et al., 2006; Lu et al., 2015) . The surgery nevertheless remains more invasive than for brain injections.
Another strategy to target specific pathways without using the Cre-Lox system is to use retrogradely transported viral vectors that encode a protein of interest (Fig. 1C) . Specificity is associated with the delivery route (projection pattern of the neurons). The human (Ad5) and canine (CAV-2) adenoviruses have been the dominant choice to date (Junyent and Kremer, 2015) despite the production of a local immune response for the AD5 (Hendrickx et al., 2014) . Several pseudotypes of AAVs have also been reported to be transported retrogradely but less efficiently and with great variability (Murlidharan et al., 2014 and Paquet, unpublished) . More recently, HIV based lentiviral vectors have been successfully pseudotyped with rabies virus glycoprotein (RV-G) to allow for retrograde transport while keeping the ease of production and other advantages of lentiviruses (Mazarakis et al., 2001; Kato et al., 2011; Hirano et al., 2013) . One approach that is growing in popularity is the combination of retrogradely transported viral vector encoding Cre followed by local injection of an AAV encoding a Cre-dependent transgene (Fig. 1D) . Recent strategies such as FLEX cassettes (Atasoy et al., 2008) , which have been developed to obtain more dependable Cre-dependent expression, have been instrumental in achieving specificity in this system. The retrograde transport of Cre offers the advantage of amplification as only few copies of the Cre are needed to produce full blown expression of the gene transduced by the local AAV vector. This combinatorial projection method also avoids local expression of the target protein in the projection site as well as expression in other pathways projecting to the site where the retrogradely transported vector is injected. An important consideration to keep in mind is that, in the end, each viral vector tool yields variable results depending of the cell type and tissue approaches; they must therefore be tested in each experimental paradigm.
A major advantage of expressing genetically-encoded fluorescent markers is the opportunity it offers to conduct very detailed morphometric analysis of the target cells (Cordero-Erausquin et al., 2009) . For this to be achieved, complete filling of even the smallest cellular profiles is important. One strategy developed to fully visualize dendritic processes for example, has been to attach a lipid modification to an FP. Myristoylation appears to result in better targeting of GFP to the membrane than other modifications such as palmitoylation or farnesylation. These modifications sometimes induce aggregation in red FPs, unfortunately, resulting in poor labeling (Kameda et al., 2008) . When trying to both visualize and control neurons with the same molecular construct, a different strategy may be useful. Indeed, it appears that using bicistronic expression of the opsin and the FP optimizes expression and membrane localization of a functional opsin together with high levels of cytoplasmic FP . Similarly, expression within axonal arborization, down to the smallest branches can be critical for both morphometric analysis (e.g., analysis of sprouting) but also for optogenetic stimulation of afferent terminals. To engineer such an axonal-filling label, the insertion of a transport signal at the end of an FP has proven successful. For instance, the 3 0 UTR of neuritin (NRN) RNA, which is known to be involved in the transport of NRN to distal axons (Merianda et al., 2013) , has been shown to improve tremendously the labeling of neural projections (Ye et al., 2016) . It should be kept in mind however that opsinsbased stimulation of synaptic terminals does not replicate the normal activation mechanism (action potential invasion). Depending on the objectives sought, more distal activation of afferents, away from the terminals, may be a more appropriate stimulus to recapitulate the normal physiological process.
While transduction of CNS neurons has been relatively straightforward, targeting peripheral (sensory) neurons has remained more challenging, in particular in adult tissue, likely because of the connective tissue surrounding nerve endings in the skin and cell bodies in the DRG. Recently, it was found, however, that sensory afferents can be selectively transduced using certain AAV serotypes when injected systemically in newborn animals (Fig. 1A Ehrengruber (2002) 3 (P3) mice yielded selective transduction in $50-60% of all DRG neurons. The advantages of this delivery method is that it is easy to perform and no surgery is required. A disadvantage is that the expression can be leaky if a recombinase system is used, since the injection is carried out in newborn mice. Intra-sciatic nerve injection of AAV6 (with a synapsin promoter) in adult mice has been reported to specifically transduce in nociceptors (Iyer et al., 2014) . The efficiency is lower compared to IP injection with only $16% of DRG neurons transduced. Specific labeling of nociceptors may be an advantage if this is the population of afferents targeted. Primary afferents can also be targeted by direct injection of lentivirus (Schweizerhof et al., 2009; Simonetti et al., 2014; Selvaraj et al., 2015) or AAV (Simonetti et al., 2014; Li et al., 2015; Vicuna et al., 2015) into the DRG. The approach is very invasive however. It was also reported that intrathecal (IT) delivery of double-stranded AAV2 (dsAAV2) (Kao et al., 2010) , AAV5 (Vulchanova et al., 2010) , AAV8 (Vulchanova et al., 2010) and lentivirus (Li et al., 2016) can transduce DRG neurons in both adult mice and rats. Pre-treatment with intravenous mannitol appears critical to increase the efficiency of the transduction (Vulchanova et al., 2010) . Both AAV5 and AAV8 preferentially transduce into large-diameter afferents. Within the small-diameter afferent population both viruses appear to transduce preferentially into the peptidergic subpopulation. The cell type preference for dsAAV2 is unknown (Kao et al., 2010 ). An advantage of intrathecal injection is that it is easier to perform than intra-sciatic injection, but the transduction rate is lower and it remains to be determined how uniform the transduction is across the DRG.
Trans-synaptic strategies
Several approaches have been used for trans-synaptic labeling or transfer of genes across synapses. The approach can be very powerful to target a population of cells that is pre-or postsynaptic to a specific element of the circuit. Retrograde trans-synaptic labeling has been used to target neurons presynaptic to projection neurons (Fig. 1C) and anterograde approaches can be used through afferent input to a specific nucleus. Strategies include using retrogradely transported viral vectors, either directly encoding a trans-synaptic protein or protein chimera. For example, the nontoxic fragment C of the tetanus toxin (TTC) can be retrogradely transported through a synapse and a GFP-Cre-TTC chimera can effectively be used to transfer GFP across synapses (Coen et al., 1997; Kissa et al., 2002) . Early strategies used rabies viruses for retrograde transsynaptic labeling. The approach is powerful for anatomical tracing, but not for functional approaches since the virus is toxic, and they require a high level of biosafety confinement. Pseudorabies virus have been an interesting alternative (Jasmin et al., 1997) . Since the virus is what is transported across the synapse, the system selfperpetuates and eventually all cells are labeled. Carefully timed interruptions of the transport is needed to interpret monosynaptic jumps. The advantage of the GFP-Cre-TTC approach is that it is the protein that is transported hence typically yielding single synapse jump. This was used successfully to identify neurons presynaptic to lamina I projection neurons (Cordero-Erausquin et al., 2009 ). Tracing of the neural circuitry has also been done with EnvA-pseudotyped G deleted Rabies virus (RVdG). This technology allows for retrograde transport and efficient trans-synaptic spread of the viral vector but works through complementation and thus requires multiple components such as a helper virus to deliver G in trans and a mouse line expressing EnvA's cognate receptor TVA (Sakurai et al., 2013; Stanek et al., 2014; Kim et al., 2016b) . For anterograde trans-synaptic tracing, transduction of wheat germ agglutinin (WGA) and WGA chimeric constructs has been mainly used (Braz and Basbaum, 2009; Gradinaru et al., 2010) . Direct synaptic coupling nevertheless needs to be verified by complementary approaches (EM or electrophysiology).
IMAGING IN PAIN PATHWAYS The in vivo challenge
With the optimization of chemical and geneticallyencoded neuronal activity indicators (Looger and Griesbeck, 2012; Storace et al., 2015) , development of microscopy technologies (Laffray et al., 2011; Sanderson et al., 2014; Winter and Shroff, 2014; Keller and Ahrens, 2015) , and improvement of light delivery tools (Aravanis et al., 2007; Zhang et al., 2010; Dufour and De Koninck, 2015) , optical recording has become one of the most popular methods to study the function of a population of neurons. In particular, the popularization of two-photon microscopy has disseminated the use of functional cellular imaging from small neuronal networks in vivo (Denk et al., 1990; Zipfel et al., 2003; Kerr and Denk, 2008) . However, compared to its rapidly growing use in the brain, especially for cortical surfaces, applications of functional imaging in DRG, spinal cord, and brainstem are still in their very early stages. Reasons include movement of DRG, spinal cord and brainstem, but also the presence of myelin, which is the most scattering element of light in brain tissue. The spinal cord is heavily covered with myelinated ascending tracks for example, significantly limiting optical access compared to cortical structures. Heavy surgical interventions (laminectomy) are often required to expose DRG, spinal cord and brainstem for imaging, making the approach highly invasive. Thus, here we will focus on advances to enable imaging in skin, dorsal roots, and spinal cord. Sensory terminals in the skin have not been directly imaged in vivo; functional imaging in the skin of the ear in vitro with GCaMP3 was used to study nerve terminals . Successful imaging in the skin is critical to understand the transduction process, including the interactions between skin cells and nerve ending, which is an essential component of the generation and modulation of signals in sensory afferents. Imaging of the skin presents many challenges, however. First, the skin is highly scattering, so light cannot penetrate very deep and only superficial layers can be imaged (typically the first 100 lm). Second, in highly vascularized skin, hemoglobin is a major obstacle; it is one of the highest light absorber below 600 nm (Zonios et al., 2001) , dramatically reducing the signal in the ultraviolet and visible ranges. Third, hairs and the skin itself are highly autofluorescent. Fourth, while studying thermal transduction may be simpler, combining high precision imaging and mechanical stimulation is very challenging. Overall, these obstacles need to be addressed before skin imaging becomes a routine reality. Hemoglobin absorption can be solved with red-shifted fluorescent sensors (emitting >650 nm). A remaining important breakthrough will be to solve the scattering problem. The advent of physiologically compatible clearing agents would be particularly enabling in this respect.
Most studies of primary afferent physiology to date have focused on recording from single or a few afferents at a time since they have relied on electrophysiological techniques. Recording from a wide population of afferents is becoming critical if one seeks to understand combinatorial nature of somatosensory coding akin to that in other sensory systems (Prescott et al., 2014) . The single neuron focus has led to the concept that sensory coding results from activity in single classes of afferents at a time. Yet, while each class of afferent may be tuned to a certain stimulus, a stimulus activates several types of afferents. Thus the problem must be addressed in terms of population coding, which calls for the ability to perform population recording (Prescott et al., 2014) . In vivo imaging of dorsal roots is one strategy to record sensory afferent responses (Vrontou et al., 2013) . The dorsal roots have the advantage that they sit at the surface of the spinal cord, thus easily accessible for optical imaging. In contrast, imaging throughout the DRG is more challenging as it is packed with highly scattering connective tissue. In contrast, cell bodies are large and allow for more robust (movementresistant) monitoring (Davalos et al., 2008) . A recent study reports recording from large numbers of DRG neurons (>1600) at low magnification with a confocal approach, but the scan speed remains limited ($0.15 Hz); high-speed functional measurements had to be performed on zoomed regions (Kim et al., 2016c) . A two-photon microscopy with fast scanning should yield deeper and faster sampling, enabling monitoring from large populations at once. Movement remains a continuous challenge with in vivo functional imaging. A few approaches have been developed to circumvent this challenge, including a real-time, adaptive movement compensation strategy (Laffray et al., 2011) . The system requires a sufficient frequency response performance to compensate movements on time scales relevant to Ca 2+ transients (from tens of Hz to kHz). Spinal dorsal horn imaging has been performed successfully to investigate the dynamics of glia morphology (Davalos et al., 2008; Davalos and Akassoglou, 2012) and function of spinal cord neurons (Johannssen and Helmchen, 2010; Ran et al., 2016) . The presence of highly scattering myelin at the surface of the spinal cord, in contrast to cortex, significantly limits depth of imaging for functional two-photon microscopy.
A major limitation for in vivo cellular imaging studies has been the need to use anesthesia. The advent of head-fixed unanesthetized preparations and microendoscopy approaches to perform in vivo functional imaging has been transformative in this respect (Helmchen et al., 2001; Dombeck et al., 2007; Dombeck and Tank, 2014; Hamel et al., 2015) . A comparable approach for skin, DRG, or spinal cord imaging is much more challenging however. The development of spinal windows (Fenrich et al., 2013; Farrar and Schaffer, 2014) or spinal microendoscopy (Belanger et al., 2012) may yield applications for unanesthetized conditions. Maintaining stability of proper registration of the imaging system, be it using a fixed stage or portable (miniaturized) design, may still remain highly challenging to withstand abrupt movements and reflex responses triggered by noxious stimuli. Many barriers remain, but the approach nevertheless deserves to be explored to be able to understand how spinal sensory processing is affected by motor action. When anesthesia remains necessary, the choice of anesthetic is critical for compatibility with Ca 2+ imaging. The commonly used fluorothane anesthetics, for example, can interfere significantly with Ca 2+ responses beyond certain doses.
The spatial resolution challenge
Immunostaining or other labeling techniques have been combined with a confocal and two-photon microscope to study the distribution and localization of different proteins. For certain types of questions, when resolving subcellular membrane trafficking, molecular interactions or functional signaling at individual synapses, spatial resolution become a critical limiting factor for optical approaches due to the diffraction limit. Several transformative strategies have been developed to improve on spatial resolution, including STED (Hell and Wichmann, 1994) , PALM (Betzig et al., 2006) and STORM (Rust et al., 2006) for both fixed tissue and live cell studies (Godin et al., 2014; Nienhaus and Nienhaus, 2016) . And single molecule studies can be used to resolve structural assemblies and oligomerization (Jonas et al., 2015 (Jonas et al., , 2016 . Single molecule tracking has revealed particularly instrumental to study receptor diffusion on the membrane which emerged as a key mechanism underlying synaptic plasticity (Choquet and Triller, 2013) . These super-resolution techniques are challenging to use in live tissues however, for two reasons. First, the large amount of time needed to acquire such highresolution images is not ideally suited to the sample being alive and moving. Second, the imaging depth in thick tissue is still limited to less than 100 lm, and the scattering limits the resolution improvements very rapidly as depth is increased: for STED, scattering has the effect of diminishing the quality of the null intensity at the center of the STED beam, and for PALM/STORM, it reduces the SNR which in turn reduces the resolution improvement. Structured illumination approaches can also be used, but are also limited for in vivo applications because they are based on widefield strategies and thus heavily affected by scattering. All of these enhanced resolution techniques rely on fluorescence however and thus the addition external labels is required. Other non-fluorescence-based resolution enhancement approaches have been developed (Dehez et al., 2013; Marquet et al., 2014) , but also remain limited for in vivo applications. Yet, the ultimate goal to understand molecular signaling in normal and pathological conditions, is to measure quantitatively protein interactions in tissue. Approaches based on resonance energy transfer have proven very powerful because they directly reveal protein interactions within a 10-nm length scale. However they rely on availability of suitable fluorescent probes, which are often complex to produce and require the use of expression systems (Gales et al., 2005) . To overcome these limitations, we developed a spatial domain fluorescence fluctuation analysis techniques which offer several advantages: it can be applied to analysis of images of both chemically fixed tissue as well as live cells, it is compatible with conventional immunolabeling approaches, it yields robust quantification even with highly heterogeneous tissue samples and provides quantitative information on both protein densities and multimeric organization. This type of approach thus opens the door to measuring protein interactions using standard fluorescence microscopy in native tissue, including human tissue, which can be key to bridge results in animal and human studies and capture the molecular underpinnings of certain pathologies (Godin et al., , 2015 .
The temporal resolution challenge
The challenge when imaging circuits is to sample a large enough number of cells at a sufficiently high frame rate to follow their dynamics (Ca 2+ or electrical signal). The simplest approach is to perform rapid scanning of the imaging laser beam along a fast axis (X) with either resonant galvo scanners or polygonal mirrors (Veilleux et al., 2008) , while completing the scanning with a slower scanner along the other axis (Y) (Fig. 2A) . Speed of acquisition can be increased with some degree of parallelization using multifocal of spinning-disk approaches. Spinning-disk approach limits signal detection however for two-photon microscopy and a temporal decorrelation strategy must be implemented for multifocal, multibeam, femtosecond pulse approaches (Fittinghoff et al., 2000) (Fig. 2A) . Other non-scanning strategies exist: temporal focusing (Oron et al., 2005) , spatial light modulators (Therrien et al., 2011) , HiLo microscopy (Mertz, 2011) . These strategies quickly show their limitations, however: circuits are rarely limited to a single well-defined 2D plane and a strategy to scan volumes is necessary (for a review see Ji et al., 2016) . Stage-scanning or rapid focus adjustments in Z are possible, but the sequential acquisition of stacks of images is often too slow for activity monitoring. There are two main strategies to increase the imaging speed: reduce the number of points imaged or parallelize the detection (Fig. 2B) . Strategies that optimize the number of cells that are imaged using a piezoelectric-mounted objective and a non-raster scan have been implemented (Gobel et al., 2007) to provide sparse sampling of a volume at 10 Hz. An extension of this strategy uses acousto-optic deflectors (AOD) to deflect the beam in 3D and sample an arbitrary sequence of points at >100 kHz (Salome´et al., 2006; Akemann et al., 2015) (Fig. 2B) . However, these two methods do not obtain images per se, and any movement in the sample will affect the resulting data. Methods that parallelize the detection can achieve higher imaging rates without sacrificing points. A promising approach for in vivo applications is SCAPE microscopy (Swept confocally-aligned planar excitation), which is essentially a light-sheet in a single objective, that permits volume imaging of neuronal circuits at video rates thanks to an oblique line scanning strategy coupled with a camera (Bouchard et al., 2015) (Fig. 2C) . Another strategy that is compatible with laser-scanning microscopes is to use Bessel beams and line focusing instead of standard point focusing to obtain a complete projection of a stack in a single image eliminating the need for z scanning (Dufour et al., 2006) . When labeled cells are sparsely distributed, a single 2D projection of a volume can be sufficient to sample from all cells (Fig. 2C) . Alternatively, stereographic images can be obtained if two images at different angles are taken (Theriault et al., 2013) .
The depth challenge
The micron-sized wavelength of light in optical imaging gives it its great spatial resolution but also consequently makes it sensitive to scattering from micron-and submicron-sized index of refraction inhomogeneities. This scattering is responsible for the low penetration depth of optical imaging. Multiphoton microscopy has supplanted confocal microscopy for most applications in thick tissue imaging since it suffers from scattering only for illumination and much less so for detection. Indeed, once the multiphoton illumination has generated a source of light at the focal spot, tissue scattering plays a mostly beneficial role in partially redirecting some of that light into the objective that would have otherwise been lost into the tissue. It is this mechanism that makes possible other contrasts based on coherent processes such as second harmonic generation (SHG) (Campagnola and Loew, 2003) , third harmonic generation (THG) (Debarre et al., 2006; Farrar et al., 2011) and coherent anti-Stokes Raman scattering (CARS) (Evans et al., 2005) . To maximize collection for any multiphoton process, objectives with a large NA are therefore important, but even more important is a large field of view to collect all of the diffuse, scattered light. Such objectives are now available from most major companies following design considerations outlined previously (Oheim et al., 2001) .
Still, poor excitation efficiency due to reduced peak intensity (loss of ballistic photons) by scattering remains the limiting factor for shallow imaging depth. This peak intensity reduction after scattering can be recovered in two ways. First, one can use high-peak intensity amplified pulses containing a larger number of photons at the expense of a lower repetition rate (Oheim et al., 2001 ). This will increase the signal with the reduction of the repetition rate. This low repetition rate however becomes an issue if it is significantly lower than the pixel clock rate. Increasing the peak intensity also brings another problem, whereby fluorescence from outside of the focal area starts adding background noise to the sig-nal and limits the overall SNR (Theer et al., 2003) . To limit this background fluorescence, three-photon excitation has been proposed since the optical sectioning from this process is more pronounced than for two-photon excitation. This was recently demonstrated to lead to an impressive 1-mm imaging depth in the cortex for selected fluorophores (Horton et al., 2013) . The second strategy to recover a large peak intensity is to use adaptive optics to pre-compensate tissue scattering. This has been done by many groups to increase imaging depth while maintaining spatial resolution, but challenges remain to extract the most of what this technique could theoretically provide (Ji et al., 2010) .
To simply bypass scattering altogether, microendoscopes (or GRIN relay lenses) can be used to bring the light directly to the area of interest either in , 2006) or use spatial light modulators to distribute the laser illumination to specific areas of the field (middle) (Therrien et al., 2011) . Finally, using a conventional galvo mirror approach, one can program the laser trajectory to intersect the points of interest within the network of cells studied (right) (Gobel et al., 2007) . These methods do not obtain images per se, and any movement in the sample will affect the resulting data. (C) Methods that minimize scanning also include light-sheet and Bessel beam microscopy. An interesting avenue for application of light-sheet microscopy to in vivo conditions is SCAPE (right), which uses an oblique illumination light-sheet allowing for the use of a single objective for both excitation and collection (Bouchard et al., 2015) . Using Bessel beams (line focusing; left) instead of standard point focusing yields a complete projection of a stack into a single image, eliminating the need for z scanning (Dufour et al., 2006; Theriault et al., 2013) .
Inscopix and Doric Lenses)
. This has been demonstrated with many multiphoton modalities to image Ca 2+ activity in the cerebellum (Barretto et al., 2009 ). However, because GRIN relay lenses must maintain a reasonable field of view, their large diameters (between 300 lm and 1000 lm) tend to be problematic if one needs to go deep in the brainstem or spinal cord of rodents, and are therefore limited to the brain after careful surgery.
CONTROLLING PAIN PATHWAYS
Beyond recording, precise activity control of subpopulations of neurons is also critical to establishing how sensory input is encoded and contribute to pain or pain modulation. To this end optogenetics strategies applications for pain research are only beginning to emerge. One reason is that several components of pain pathways (DRG, spinal cord, and brainstem) have remained difficult to access, mainly because they are encased within the vertebral column. Even skin, which is highly scattering (see above) has been a significant obstacle at first.
Contactless, activation of pain pathways
One initial breakthrough has been the design of a mouse line where Nav1.8 afferents (expressing ChR2) could be activated by light shining across the skin (Daou et al., 2013) . The advantages of this tool are manifold. First, it allows selective activation of nociceptors, which has not been possible even with electrical stimulation. Second, activation is achieved without touching the skin, which avoid other tactile stimulation, allowing isolation of that input. Third, it allowed performing controlled activation of the same afferent populations across preparations: from spinal cord explants to intact animals. Complementary approaches were developed to produce selective inhibition of sensory afferent endings in the skin (Iyer et al., 2014; Daou et al., 2016) . These strategies have the disadvantage that maintaining well-controlled stimuli is difficult as the animal is moving, especially when attempting to stimulate nociceptors. Thus to produce sensitization with repetitive stimulation of nociceptors, animals had to be briefly anesthetized (Bonin and De Koninck, 2014) . One way to overcome this limitation is to introduce the light source into the body. This was achieved using wireless microLED implanted in different regions (e.g., subcutaneously, at the spinal cord surface, or the brain (Montgomery et al., 2015 (Montgomery et al., , 2016 (Fig. 3B) . One drawback of this approach is that the power that can be deployed to date is insufficient for effective activation of inhibitory opsins (ArchT, NpHR). Improvements in opsins will likely help overcome such limitation. Recently, use of the step-function inhibitory opsin SwiChR has been shown to produce effective analgesia for up to 60 s with just one brief pulse of blue light delivered transdermally ). An alternative strategy to microLED implants has been to use an epidural fiber, which can be connected to an external source; it provided sufficient power to produce analgesia in mice where ArchT was expressed in afferent nociceptors (Bonin et al., 2016) (Fig. 3A) . The advantage of the latter design is that it can also be engineered for concurrent photometric measurements (see below). Wireless approaches often have the current drawback that they require the use of resonant cavity for energy transfer and movement of the animal can affect the orientation of the receiving coil, which can affect the efficiency of energy transfer. Moreover, the resonant cavity limits flexibility for certain behaviors. An alternative wireless system that harvests its energy from radio frequency (RF) transmitter has recently been developed, which eliminates the need for resonant cavity (Park et al., 2015) .
Guiding light
Fiber-optics technology has been at the core of development for optogenetics. They have represented the tool of choice to reach deep brain structures, but also hard-to-reach areas (Dufour and De Koninck, 2015; Bonin et al., 2016) . The physical parameters of the fiber (core size, numerical aperture) are important parameters to determine the illumination volume achieved to match the needs of the experiment (for detailed review of practical considerations guiding the choice of fiber probe and parameters to use, see Dufour and De Koninck, 2015) . Microengineering fiber tip and combination with microoptical components open a wide array of possibilities in using fiber optics technologies (Fig. 4A) , including focusing, side illumination, diffusion, etc. Fiber optics can also be tapered (e.g., pulled like conventional glass micropipettes used for electrophysiological recording) down into very small tips that can be particularly instrumental for measurements from few cells, or even single cells (LeChasseur et al., 2011; Dufour et al., 2013) (Fig. 4B) . Choosing (or engineering) fibers of the right core size with the right tip size is important because larger size fibers must be positioned further away from the target nucleus to stimulate. The farther the fiber tip, the weaker the signal at the target site due to scattering. In excitation mode, one can always increase the intensity of the source, but care must be taken not to reach toxic or damaging intensities (Dufour and De Koninck, 2015) . Another important key feature of fiber probes is that they can be used not only for delivering light to a target tissue but also to collect emitted light. Even single-core fibers, while they cannot serve easily for imaging, can be very instrumental for collecting information, especially considering the growing array of sensors available and their very specific targeting. Hence, akin to specificity achieved by optogenetic stimulation, regardless of the spatial confinement of the light, specificity in collected signals from the tissue can be achieved using a non-imaging single-core fiber. By integrating information emanating from a volume of cells, spatial information is not necessary as long as the signal originates from specific subpopulations of cells or even specific subcellular compartments (e.g., nucleus, endoplasmic reticulum, mitochondria). This type of fiberbased photometry has the advantage that it can rely on optical probes that are much less invasive than microendoscopes for example (Kim et al., 2016a) . Multimode fibers are compatible with multicolor acquisition to the same extent that imaging devices are (Dufour et al., 2013) . At the single-cell level, combined optical and electrical recording can be particularly powerful to synchronously probe intracellular signaling events and firing activity of the cells (Fig. 4B) .
Multimodality
An important asset of optical modalities and optical devices is that they can easily be combined with other modalities, such as electrophysiological recording. There is no good reason to set aside the ability to record electrophysiologically the activity of neurons, even in the advent of voltage-sensitive dyes. Indeed, unlike fluorescence measurements, electrophysiological recordings come at virtually no cost; no dye introduction or transfection is needed. Extracellular recording is noninvasive to the cell, minimally fades with time (unlike photobleaching of fluorescent dyes) and is non-toxic (no photochemistry involved). Mixed optical and electrographic probes have thus been designed and termed optrodes or optodes and clever design can allow co-registered optical and electrical recording from single cells (LeChasseur et al., 2011) or even a combination of single-cell and field recording (Dufour et al., 2013) (Fig. 4B) . Combined optical and electrical probes come in many flavors, including electrode arrays. For a detailed review of design strategies see (Dufour and De Koninck, 2015) . The choice of the electrical recording element is an important factor when choosing electrode as the illumination of certain metal electrodes can produce undesired photoelectric artifacts . In arrays, the spatial relationship between the optical probes and the electrode probes varies and, while 1:1 spatial coregistration would ultimately be ideal, it is not necessarily needed if the optical probes are only desired to produce broad stimulation. Other modalities can also be combined and considerable efforts are deployed to produce miniaturized probes and new materials for combined optical, electrical and chemical delivery and sensing. No single design offers a universal solution, but the combination of optical and electrical elements of different sizes and geometries can be permutated to allow for a large spectrum of optrode designs addressing different needs (see Fig. 4C ). The need to take full advantage of optogenetic and multimodal monitoring in freely behaving animals has driven the design of wireless device (see above and Fig. 4D ). While not always necessary, they can become quite useful when studying complex behavior requiring the animal to move freely in confined areas (e.g., small tunnels) or engaged in social interactions. An important challenge is the combination of multiple signals (e.g., electrical and optical), which is not trivial (Gagnon- (Fig. 4D ). To manage a high channel count and the high sampling rates necessary for electrical recordings with sufficient information about spike shape, strategies must be developed to introduce maximum onchip processing capabilities and data compression algorithms before the signals are transferred wirelessly (Gagnon-Turcotte et al., 2016) (Fig. 4D ).
Scaling to humans; size matters
A final, often overlooked, consideration regarding translation of optogenetics to higher species, and in particular to human applications, is that the increase in size of brain structures presents a major challenge. Indeed while distance for single scattering events remains the same as the tissue grows, the distance between elements of interest increases. The result is a dramatic decrease in efficient light transport from the source to the target areas in tissue. Making things worse, the degree of myelination (the major source of light scattering in brain tissue) disproportionately grows in primates and humans (two-to threefold). Thus, even if the prospect of using viral vector-mediated somatic gene transfer for clinical applications in humans is not necessarily so distant (Kaufmann et al., 2013) , effective light delivery in human tissue is an obstacle that will have to be tackled with the design of miniaturized distributed delivery systems.
The challenge of gene therapy
The efficiency of any gene therapy first relies on vector delivery and expression in the appropriate cell type and so far, this has been extremely difficult to achieve. For pain therapeutics, while several strategies appear promising at the pre-clinical level, very few advance to the next phases (Guedon et al., 2015) . Herpes Simplex Virus-1 (HSV-1) based vectors, which have a natural tendency to target sensory neurons have been used in several models of pain and AAVs, which have a broader spectrum of targets have also shown some promising results (Beutler and Reinhardt, 2009 ). Adenoviral and lentiviral vectors have also been used but none appear to possess all the required qualities for a perfect gene transfer vehicle in humans. Major barriers to viral vector-based gene therapy include induction of an immune response, the presence of neutralizing antibodies, delivery/transport to the target cells, and clearance of the vector through the liver. Much work remains to overcome these barriers. To date, most efforts have been directed to improvement of specific characteristics of existing vectors through rational design and directed evolution (Kotterman and Schaffer, 2014) . Variant designs and capsid modification are promising avenues and this field evolves rapidly. Other barriers to this fast advancing field are the constraints of high regulation scrutiny. As observed with research grade viral vectors, production conditions of these tools are critical as different results can be obtained with seemingly identical general vector design. If this therapeutic avenue is to spread, requirements for large quantities, uniformly produced, high titer and better-characterized products are expected to become available (van der Loo and Wright, 2016).
PROBING WITHOUT LABELS
Many naturally-occurring molecules are fluorescent, with some of them having a brightness that is even comparable to some of the engineered proteins (Zipfel et al., 2003) . These endogenous signals, although usually discovered serendipitously, offer molecular specificity, are naturally perfectly safe, and do not suffer from the many difficulties associated with exogenous labeling (protocols, inhomogeneities, etc. . .). For these reasons, label-free approaches have been developed and have had success for a number of targets such as FAD, NADH, serotonin, lipids and myelin, and collagen. It has been shown for instance, that FAD/NADH can be used to assess the metabolism of cells, that two-photon fluorescence at 600-nm excitation can be used to image serotonin, and that activity modulates slightly the fluorescence of flavoprotein when excited around 400 nm (Maiti et al., 1997; Jongen et al., 2014) . Despite the significant advantage of label-free strategies, their use is often limited by the overall instability of the fluorescence (photobleaching or photoswitching). In addition, they usually are not targeting the optimal molecule for a particular readout (e.g., flavoprotein for activity).
A technique that has seen good adoption is vibrational microscopy, which relies on molecular vibrations for specificity. Termed under the name ''Coherent Raman" techniques, CARS and Stimulated Raman Scattering (SRS) microscopies make use of two laser pulses at different frequencies where the difference is equal to vibration frequency of a molecule. For CARS, the molecule will re-emit a photon at a different and shorter wavelength in a process that makes it behave in practice like multiphoton-excited fluorescence. This makes the CARS modality compatible with laserscanning fluorescence microscopy. SRS on the other hand, relies on the modulation of one beam to impart a very small modulation on the other beam that is proportional to the number of vibrating molecules. This makes SRS ideal for spectroscopy applications since the signal is linear with the concentration as opposed to CARS where it is quadratic. It however requires modifications to the microscope that are non-standard for fluorescence microscopes. Certain vibrations such as the stretch vibration of CH 2 in the high wavenumber region can be used to image myelin, since the lipids that make up the membranes are rich in CH 2 . This has then been used to quantify neurodegeneration in nerve crush injuries, a common model of nerve injury-induced neuropathic pain. This is illustrated in Fig. 5A , where a panorama of the myelin across the nerve is performed with CARS microscopy, one week after injury. In this example, the mapping spans several millimeters of nerve on both sides of the injury site, across healthy regions, with intact myelinated axons, to areas with Wallerian degeneration distal to the lesion with respect to the cell bodies of the sensory neurons. Thus an optical microscopy approach like CARS allows for rapid spanning of large areas of tissue, while preserving submicron scale resolution. Fig. 5B depicts the well aligned and globally oriented myelin sheaths of live white matter in rat spinal cord tissue. Using reconstructed transverse image from z-stack -a contactfree CARS optical slice- (Fig. 5C) , morphometric analysis such as myelin thickness measurements can be conducted over time (Fig. 5D-F) (Belanger et al., 2009 (Belanger et al., , 2012 Begin et al., 2013 Begin et al., , 2014 . With additional data taken at different time points, demyelination at 2-weeks post-injury followed by remyelination at 4-weeks could be measured with cellular resolution (Henry et al., 2009; Belanger et al., 2011) indicating that such an approach can be used for quantitative longitudinal studies in vivo (Fig. 5F) . A recent advance in CARS microscopy is the use of polarization, increasing sensitivity down to molecular organization. Polarization CARS (P-CARS) uses excitation beams with different states of polarization and takes advantage of the high level of symmetry of certain structures like the myelin sheaths (Fig. 5G) . Indeed, CH 2 mole-cules are not randomly distributed within the diffraction limited excitation volume. Their molecular dipoles are partially aligned and this distribution can be characterized by a main orientation (Belanger et al., 2015) . Using this principle, P-CARS was recently used to assess the myelin molecular order during promyelination chemical treatments in zebrafish. The approach revealed myelin discontinuities that were invisible with regular CARS (Fig. 5H-I ).
Subtle alterations to the nanoscopic spatial organization of the several concentric lipid lamellae forming myelin sheaths thus became detectable optically by P-CARS . Hence CARS imaging provides quantifiable endogenous signal, which can be used to assess myelin health and has the potential to become a powerful tool in the quest to understand nerve degeneration and repair. Measurements can be performed across time in vivo. Note the myelin thickness decreases at 2-weeks post-injury, revealing significant demyelination. At 4-weeks, myelin thickness augments, showing partial yet incomplete remyelination. Modified from Belanger et al. (2011) . (G) Polarization dependence plot, the black curve is from the focal myelin discontinuity and the red one from the normal region. (H) CARS image of a Mauthner axon in a zebrafish. Scale bar = 3 lm. (I) P-CARS image of the same axon revealing discontinuity on the left side. Black rectangles indicate where the polarization dependence plot in (G) was taken. Same scale bar as (H), (H-I) are modified from Turcotte et al. (2016) .
OUTLOOK
The array of tools becoming available to measure and manipulate cellular and molecular events in intact tissue is growing at an accelerated pace. The level of spatial and temporal precision achievable is unprecedented, but it is the ability to interrogate cell function in behaving animals that is making the convergence of technologies particularly transformative for the field of pain. This is because the pain system involves so many interacting components. Thus, on the one hand, it is difficult to ascertain the contribution and net functional impact of specific cellular mechanisms at the behavioral level without measuring and manipulating both in the same setting. On the other hand, this or that mechanism is likely to be engaged, or heavily modulated, by a multitude of factors, including the behavioral context in which the subject is placed. Multimodal, minimally invasive technologies are essential to untangle the complex interplay that exist between cell signaling and behavior. Yet, in the context of the drug discovery and validation process, the enormous adaptability of the CNS represents an equally important challenge, because the diseased brain can easily adjust to drug treatment, effectively counteracting its effectiveness (Ratte and Prescott, 2016) . The ability to measure molecular processes over time in a non-invasive fashion becomes critical to understand the response of the CNS to drug treatment. The emerging and converging lightbased technologies offer unprecedented opportunities to fill this important gap in a translational research endeavor.
